Keith A. Goldan, Chief Financial Officer at Syndax Pharmaceuticals Inc (SNDX), sold 7,554 shares at $15.50 ($117K) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Open-market sale of $117k SNDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.50 | 3,777 | $59K | 50.0% |
| 2 | $15.50 | 3,777 | $59K | 50.0% |
| Total | $15.50 avg | 7,554 | $117K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-06 | $43K | — | Filing → |
| SNDX | SELL | 2025-07-18 | $12K | — | Filing → |
| SNDX | BUY | 2024-06-17 | $25K | — | Filing → |